Gene · 1282
Papers3,934
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,934
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pericyte dysfunction and impaired vasomotion are hallmarks of islets during the pathogenesis of type 1 diabetes. | Cell Rep | 2023 | 37531253 | PubTator, text mining | PubMed |
| Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion. | Cancer Res Commun | 2023 | 37529399 | PubTator, text mining | PubMed |
| Protective effects of red orange (Citrus sinensis [L.] Osbeck [Rutaceae]) extract against UVA-B radiation-induced photoaging in Skh:HR-2 mice. | Nutr Res Pract | 2023 | 37529272 | PubTator, text mining | PubMed |
| Derivation and characteristics of induced pluripotent stem cells from a patient with acute myelitis. | Front Cell Dev Biol | 2023 | 37519296 | PubTator, text mining | PubMed |
| Interactions between circRNAs and miR-141 in Cancer: From Pathogenesis to Diagnosis and Therapy. | Int J Mol Sci | 2023 | 37511619 | PubTator, text mining | PubMed |
| Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up. | Int J Mol Sci | 2023 | 37511281 | PubTator, text mining | PubMed |
| The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer. | Int J Mol Sci | 2023 | 37511248 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures. | Int J Mol Sci | 2023 | 37511137 | PubTator, text mining | PubMed |
| Trends and hotspots in gene research of epilepsy in children: A review and bibliometric analysis from 2010 to 2022. | Medicine (Baltimore) | 2023 | 37505157 | PubTator, text mining | PubMed |
| A single nuclei atlas of aging human abdominal subcutaneous white adipose tissue. | Res Sq | 2023 | 37503028 | PubTator, text mining | PubMed |
| Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models. | J Clin Invest | 2023 | 37498672 | PubTator, text mining | PubMed |
| The benefits and pitfalls of machine learning for biomarker discovery. | Cell Tissue Res | 2023 | 37498390 | PubTator, text mining | PubMed |
| Fetal MRI of the supratentorial brain abnormalities: what we should know about ventriculomegaly? | Jpn J Radiol | 2023 | 37493877 | PubTator, text mining | PubMed |
| Circadian regulation in aging: Implications for spaceflight and life on earth. | Aging Cell | 2023 | 37493006 | PubTator, text mining | PubMed |
| Integrated single-cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial-fibroblast interactions in recurrent bladder cancer. | Clin Transl Med | 2023 | 37488671 | PubTator, text mining | PubMed |
| Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. | Nat Cancer | 2023 | 37488416 | PubTator, text mining | PubMed |
| m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer. | Sci Rep | 2023 | 37488178 | PubTator, text mining | PubMed |
| Exome Sequencing and the Identification of New Genes and Shared Mechanisms in Polymicrogyria. | JAMA Neurol | 2023 | 37486637 | PubTator, text mining | PubMed |
| CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target. | Front Immunol | 2023 | 37483608 | PubTator, text mining | PubMed |
| Comprehensive analysis of intercellular communication in the thermogenic adipose niche. | Commun Biol | 2023 | 37479789 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1282/papers?page=27